Bruker Corporation (Nasdaq: BRKR), a leading supplier of single-plane illumination microscopy (SPIM) technology for research on live cells and cleared biological samples, today announced that two Luxendo MuVi™ and LCS SPIM™ light-sheet microscopes have been installed by Memorial Sloan Kettering Cancer Center (MSK). The funding for the two light-sheet fluorescence microscopes was supported by Cycle for Survival (https://www.cycleforsurvival.
Image Credit: Bruker Nano Surfaces
“By understanding how cells mobilize to build organs, researchers can glean insights into why some cells become cancerous and lead to organ destruction. Instruments such as these are useful for imaging across differing length scales — from subcellular to single cells to tissue-level processes — allowing researchers to study cellular dynamics and cellular motion, processes that enable cells to metastasize.”
Dr. Anna-Katerina Hadjantonakis, MSK Chair of the Developmental Biology Program
Light-sheet fluorescence microscopy has emerged as a uniquely powerful method for high-resolution, cleared-sample and dynamic biological imaging. We couldn’t be more pleased that our technology will be assisting the great MSK researchers and programs in such important work.”
Dr. Lars Hufnagel, Vice President and General Manager, Bruker’s Luxendo light-sheet microscopy business